Patent details

Basic Information

Publication number:

EP3377908

PCT Application Number:

US2016062075

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168095826

PCT Publication Number:

WO2017087409

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BIOMARKER OF POLYCYSTIC KIDNEY DISEASE AND USES THEREOF

French Title of Invention:

BIOMARQUEUR DE MALADIE POLYKYSTIQUE DES REINS ET UTILISATIONS ASSOCIÉES

German Title of Invention:

BIOMARKER VON POLYZYSTISCHER NIERENKRANKHEIT UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

15/11/2016

Grant date:

05/08/2020

EP Publication Date:

26/09/2018

PCT Publication Date:

26/05/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/08/2020

EP B1 Publication Date:

05/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/11/2020

Expiration date:

15/11/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/07/2020

 

 

Name:

Genzyme Corporation

Address:

50 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

WEEDEN, Timothy E.

Address:

United States (US)

2

Name:

BUKANOV, Nikolai

Address:

United States (US)

3

Name:

MORENO, Sarah

Address:

United States (US)

Priority

Priority Number:

201562257089 P

Priority Date:

18/11/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/137; A61K 31/166; A61K 31/439; A61P 13/12; G01N 33/68;

Publication

European Patent Bulletin

Issue number:

202032

Publication date:

05/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages